New England Capital Financial Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
ECSS
New England Capital Financial Advisors's MRK Position: Q2 2026 in Review
New England Capital Financial Advisors increased its Merck (MRK) stake by 0.5% in Q2 2026, buying an estimated $1.29K and bringing the position to 2,193 shares worth $282K. The position accounts for 0.07% of the portfolio, ranked #53.
New England Capital Financial Advisors first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $312K in Q1 2024. 1,865 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- New England Capital Financial Advisors held 2,193 shares of Merck worth $282K as of Q2 2026.
- New England Capital Financial Advisors bought 11 Merck shares in Q2 2026, an estimated $1.29K.
- Merck made up 0.07% of New England Capital Financial Advisors's portfolio in Q2 2026, its #53 holding.
- New England Capital Financial Advisors first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
- New England Capital Financial Advisors's Merck position peaked at $312K in Q1 2024.
- 1,865 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.